Published in Immunology on January 01, 1971
The requirement of more than one antigenic determinant for immunogenicity. J Exp Med (1969) 5.61
Chemical and serological studies with an iodine-containing synthetic immunological determinant 4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP) and related compounds. Immunology (1966) 4.08
Thymus dependence of antibody response: variation with dose of antigen and class of antibody. Nature (1968) 3.79
IMMUNOLOGICAL SPECIFICITY OF THE SECONDARY RESPONSE WITH DINITROPHENYLATED PROTEINS. Proc Soc Exp Biol Med (1963) 3.17
Secondary antibody responses in haptenic systems: cell population selection by antigen. J Immunol (1967) 3.01
The morphology of immune reactions in normal, thymectomized and reconstituted mice. I. The response to sheep erythrocytes. Immunology (1969) 2.49
The relative affinity of antibodies synthesized in the secondary response. J Exp Med (1967) 2.33
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
Symposium on in vitro studies of the immune response. I. Variations in the immune response to a simple determinant. Bacteriol Rev (1966) 1.65
Regulation of cellular antibody synthesis. Cellular 7S production and longevity of 7S antigen-sensitive cells in the absence of antibody feedback. J Exp Med (1968) 1.42
Determination of 19S and 7S components in an anti-hapten antibody. Ann Med Exp Biol Fenn (1967) 1.34
Heterologous carriers in the anamnestic antihapten response. J Exp Med (1968) 1.17
Effect of the number of primed cells on the production of IgM and IgG antibodies in an adoptive secondary response. Int Arch Allergy Appl Immunol (1968) 1.11
Antibody production by primed restimulated adult spleen cells transferred to neonatal and adult recipients. Ann Med Exp Biol Fenn (1966) 0.80
Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis (1989) 3.67
Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens. J Exp Med (1970) 3.08
Different Ly antigen phenotypes of in vitro induced helper and suppressor cells. Nature (1975) 2.91
Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation. Immunology (1969) 2.71
The role of cell number and source in adoptive immunity. Immunology (1965) 2.68
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
The effect of antigen dosage on the response of adoptively transferred cells. Immunology (1965) 2.59
Inherited immunoglobulin idiotypes of the mouse. Immunol Rev (1977) 2.29
Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction. Eur J Immunol (1976) 2.05
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol (1984) 1.98
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand (1969) 1.91
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis (1992) 1.90
Inheritance of antibody specificity. I. Anti-(4-hydroxy-3-nitrophenyl)acetyl of the mouse primary response. J Exp Med (1974) 1.82
Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77
Strain differences in the fine specificity of mouse anti-hapten antibodies. Eur J Immunol (1973) 1.69
Suppressor cell induction in vitro. I. Kinetics of induction of antigen-specific suppressor cells. Eur J Immunol (1976) 1.65
Isolated hapten-binding receptors of sensitized lymphocytes. I. Receptors from nylon wool-enriched mouse T lymphocytes lack serological markers of immunoglobulin constant domains but express heavy chain variable portions. Eur J Immunol (1977) 1.61
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
The diversity and specialization of immunocytes. Prog Allergy (1970) 1.54
Anti-oxazolone hybridomas and the structure of the oxazolone idiotype. J Immunol (1983) 1.52
Assay of anti-hapten antibody with the aid of hapten-coupled bacteriophage. Immunology (1966) 1.48
T cell responses to PPD in BCG-vaccinated children with insulin-dependent diabetes mellitus and controls. Acta Paediatr (1994) 1.39
Conditions for inducing T helper cells in vitro. Scand J Immunol (1975) 1.39
The four subclasses of IgG can be isolated from mouse serum by using Protein A-Sepharose. Scand J Immunol (1981) 1.37
Determination of 19S and 7S components in an anti-hapten antibody. Ann Med Exp Biol Fenn (1967) 1.34
Affinity requirements for antibody assays mapped by monoclonal antibodies. J Immunol (1983) 1.33
Analogies between lymphocyte receptors and the resulting humoral antibodies. Transplant Rev (1970) 1.29
A mendelian idiotype is demonstrable in the heteroclitic anti-NP antibodies of the mouse. Eur J Immunol (1978) 1.29
Single lymph node cells producing heteroclitic bacteriophage antibody. J Immunol (1965) 1.28
IgG subclasses of pneumococcal antibodies--effect of allotype G2m(n). Scand J Immunol (1989) 1.26
The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay. Eur J Immunol (1984) 1.25
Cellular heterogeneity in the production of an anti-hapten antibody. J Exp Med (1967) 1.22
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22
A comparative investigation of the generation of specific T cell-helper function induced by Streptococcus mutans in monkeys and mice. J Immunol (1980) 1.21
Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology (1996) 1.19
Immunogenic properties of alpha (1----6) dextran, its protein conjugates, and conjugates of its breakdown products in mice. Scand J Immunol (1984) 1.17
Generation of specfic T-cell suppressor function induced by Streptococcus mutans in monkeys and mice. Infect Immun (1979) 1.15
ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab (2000) 1.14
Haptenated bacteriophage in the assay of antibody quantity and affinity: maturation of an immune response. Immunochemistry (1970) 1.14
Antigen--antibody complexes as blocking factors on the T lymphocyte surface. Soc Gen Physiol Ser (1974) 1.13
Isotype concentrations of human antibodies to group A meningococcal polysaccharide. J Immunol (1986) 1.12
Effect of the number of primed cells on the production of IgM and IgG antibodies in an adoptive secondary response. Int Arch Allergy Appl Immunol (1968) 1.11
Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin. Scand J Immunol (1988) 1.11
Current concepts of the antibody response: heterogeneity of lymphoid cells, interactions, and factors. Cold Spring Harb Symp Quant Biol (1977) 1.11
Antigenicity of dextran-protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling. J Immunol (1989) 1.11
Proportions of Ig classes and subclasses in rubella antibodies. Scand J Immunol (1985) 1.10
Genetics of mouse antibodies. II. Recombination between VH genes and allotype. Eur J Immunol (1975) 1.10
IgG subclass distributions in anti-hapten and anti-polysaccharide antibodies induced by haptenated polysaccharides. Eur J Immunol (1983) 1.10
Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods (1992) 1.09
Lack of heterogeneity in antihapten antibodies of a phylogenetically primitive shark. Nature (1980) 1.07
Biotypes of Arcanobacterium haemolyticum. J Clin Microbiol (1994) 1.06
Structural characteristics of antigen-specific suppressor factors: definition of 'constant' region and 'variable' region determinants. Thymus (1979) 1.06
Selective inhibition of the secondary response of primed cells by incubation with hapten. Immunology (1968) 1.06
Anti-hapten antibodies in normal sera. Eur J Immunol (1971) 1.06
Blocking antigen-antibody complexes on the T-lymphocyte activation during in vitro incubation before adoptive transfer. Immunology (1975) 1.05
Enrichment of antigen-specific helper and suppressor T cells. Nature (1976) 1.04
Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes (1986) 1.04
Salmonella antigen 12-2: genetics of form variation. Ann Med Exp Biol Fenn (1966) 1.02
Inheritance of antibody specificity. IV. Control of related molecular species by one VH gene. Cold Spring Harb Symp Quant Biol (1977) 1.00
Concentrations of three hapten-binding immunoglobulins in pooled normal human serum. Eur J Immunol (1976) 0.99
Antibody responses in arthritic and uncomplicated Yersinia enterocolitica infections. J Clin Immunol (1985) 0.98
Affinity of IgM and IgG antibodies. Immunochemistry (1970) 0.98
Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol (1979) 0.98
Standard sera in solid-phase immunoassays. Eur J Immunol (1983) 0.97
Induction of human antigen-specific suppressor factors in vitro. Clin Exp Immunol (1981) 0.97
Modification of bacteriophage with hapten-epsilon-aminocaproyl-N-hydroxysuccinimide esters; increased sensitivity for immunoassay. Immunochemistry (1975) 0.97
Immunological cross-reactions within a family of related haptens. Immunochemistry (1972) 0.96
Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age. J Infect Dis (1988) 0.96
Alpha-mannosidase: a rapid test for identification of Arcanobacterium haemolyticum. J Clin Microbiol (1994) 0.96
Extensive allelic sequence variation in the J region of the human immunoglobulin heavy chain gene locus. Eur J Immunol (1995) 0.96
Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation. J Clin Lab Immunol (1979) 0.95
Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. Clin Infect Dis (1995) 0.95
Isotypes of antibodies induced by plain dextran or a dextran-protein conjugate. Eur J Immunol (1985) 0.94
Suppression or augmentation of the antihapten response in mice by antibodies of different specificities. J Exp Med (1973) 0.94
Mouse Ig coded by VH families S107 or J606 bind to protein A. J Immunol (1990) 0.94
Adult murine T cells activated in vitro by alpha-fetoprotein and naturally occurring T cells in newborn mice: identity in function and cell surface differentiation antigens. Proc Natl Acad Sci U S A (1978) 0.93
Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens. Immunology (1984) 0.92
Half-life of the maternal IgG1 allotype in infants. J Clin Immunol (1993) 0.92
Allotype-associated differences in concentrations of human IgG subclasses. J Clin Immunol (1991) 0.92
Reactive arthritis associated with Shigella sonnei infection. Arthritis Rheum (1988) 0.92
The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. Clin Exp Immunol (1988) 0.92
Antigen-binding T cells as helper cells. Separation of helper cells by immune rosette formation. J Exp Med (1975) 0.92
Antimicrobial susceptibility of Arcanobacterium haemolyticum. Antimicrob Agents Chemother (1994) 0.92
Effect of cyclosporin A on in vitro proliferative activity and immunoglobulin synthesis of isolated human lymphoid cell subpopulations. Clin Exp Immunol (1981) 0.91
Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J Infect Dis (1992) 0.91
Decreased expression of protectin (CD59) in gut epithelium in ulcerative colitis and Crohn's disease. Hum Pathol (1999) 0.91
Specifically cytotoxic human and mouse lymphoid cells induced with antibody or antigen-antibody complexes. J Immunol (1975) 0.90
High frequency of septicaemia in an outbreak of Salmonella stanley infections. Scand J Infect Dis (1996) 0.90
The range and fine specificity of the anti-hapten immune response: phylogenetic studies. J Immunogenet (1982) 0.90
Carrier preimmunisation in the anti-hapten response of a marine fish. Nature (1975) 0.90
Oligomeric IgA: the major component of the in vitro primary response of mouse spleen fragments. J Exp Med (1973) 0.89
Failure to demonstrate public idiotypes on cytolytic cells with specificity for NP-coupled syngeneic cells. Scand J Immunol (1980) 0.89
Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections. Clin Exp Immunol (1985) 0.89
Antibody affinity in mice with the CBA/N defect. J Immunol (1980) 0.89
Partial characterization of murine and monkey helper factor to a streptococcal antigen. Immunology (1980) 0.89
The protective capacity of immune sera in experimental mouse salmonellosis is mainly due to IgM antibodies. Immunol Lett (1982) 0.89